A mild symptom was bothering a young dad. He had Stage IV lung cancer.“Endurance athlete Kevin Humphrey was used to discomfort. He regularly participated in ultramarathons and other intense events. Swimming, biking and running dozens of miles at a time was standard...
LUNGevity Foundation Launches 2025 Lung Cancer Awareness Month with 60,000 White Flags on the National Mall in Washington DC“WASHINGTON, Nov. 3, 2025 /PRNewswire/ — This November, during Lung Cancer Awareness Month (LCAM), LUNGevity Foundation will lead a...
The New Lung Cancer Divide: Rural, Low-Income Young Adults Left Behind“A sweeping U.S. analysis of 18,595 people aged 18–50 diagnosed with early-onset non–small cell lung cancer (NSCLC) has a blunt message: outcomes hinge not only on tumor biology but on where you...
Personalized cancer vaccines: A new frontier in lung cancer treatment and prevention“Despite declining tobacco use, lung cancer remains the leading cause of cancer-related death worldwide. As oncologists seek more-effective and individualized therapies, Mayo Clinic...
Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics“ATNM-400 is...
FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer“Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase III IMforte study. First...
More News and Updates